RESERVOIR NEUROSCIENCE, INC.

Profile

Company Names

RESERVOIR NEUROSCIENCE, INC.

Addresses

665 3RD STREET, STE. 250, SAN FRANCISCO, CA 94107

6460 HOLLIS ST, SUITE A, EMERYVILLE, CA 94608

6460 HOLLIS ST., SUITE A, EMERYVILLE, CA 94608

Phone Numbers

507-304-0565

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$8,964,994.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-06-08 
$2,999,999.00 
$8,000,000.00 
$5,000,001.00 
Equity 
2
2023-11-14 
$2,099,999.00 
$4,099,998.00 
$1,999,999.00 
Equity 
1
2021-08-06 
$3,864,996.00 
$8,814,999.00 
$4,950,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK 
 
BURGERMEISTER 
DIRECTOR
ELASTRIN THERAPEUTICS, INC.   |  REVEL PHARMACEUTICALS INC.   |  RESERVOIR NEUROSCIENCE, INC.
AARON 
 
FRIEDMAN 
EXECUTIVE OFFICER, DIRECTOR
RESERVOIR NEUROSCIENCE, INC.
TRACY 
 
SAXTON 
DIRECTOR
PANOPTICA, INC.   |  SUTROVAX, INC.   |  LUMOS PHARMA, INC.   |  ITERUM THERAPEUTICS LTD   |  THERINI BIO, INC.   |  RESERVOIR NEUROSCIENCE, INC.   |  MINDIMMUNE THERAPEUTICS, INC.
VLADIMIR 
 
SENATOROV 
EXECUTIVE OFFICER, DIRECTOR
RESERVOIR NEUROSCIENCE, INC.
BRIAN 
 
SLINGERLAND 
DIRECTOR
STEM CENTRX INC   |  RESERVOIR NEUROSCIENCE, INC.
JAMES 
 
SUMMERS 
DIRECTOR
RESERVOIR NEUROSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-08 
2023-11-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-14 
2021-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#